Research Projects EU financed projects 2007-2013
Projects

EU finansed projects 2007-2013

1DP/1.1.1.2.0/09/APIA/VIAA/150
The investigation of molecular and genetic mechanisms of pathogenesis and the development of novel means for diagnosis and therapy

2013/0023/1DP/1.1.1.2.0/13/APIA/VIAA/037

 Research of anti-tumor resistance molecular and cellular mechanisms

2013/0039/1DP/1.1.1.2.0/13/APIA/VIAA/038

Paleopathological and molecular genetic studies of anthropological materials obtained from archaeological excavations in a territory of Latvia

2013/0026/1DP/1.1.1.2.0/13/APIA/VIAA/006

Total synthesis of analogues of natural compounds and investigation of anti-cancer activity

 

2011/0045/2DP/2.1.1.3.1./11/IPIA/VIAA/001
The Development of the Scientific Infrastructure of the Pharmaceutical and Biomedical Research Centre of National Importance

2DP/2.1.1.2.0/10/APIA/VIAA/004
The Integration of Latvian Biomedical Research in the European Research Area

2010/0311/2DP/2.1.1.1.0/10/APIA/VIAA/022
Development and validation of novel DNA tests for diagnosis applicable in clinical practice

2010/0223/2DP/2.1.1.1.0/10/APIA/VIAA/025
New tests for the diagnosis of inherited neuromuscular diseases

2010/0312/2DP/2.1.1.1.0/10/APIA/VIAA/032
High-throughput screening of sortase inhibitors for antimicrobial therapy

 2010/0231/2DP/2.1.1.1.0/10/APIA/VIAA/044
Development of diagnostic and prognostic tests for malignancies based on autoantibody detection

 2010/0211/2DP/2.1.1.1.0/10/APIA/VIAA/048
Development of the prototype of new universal Hepatitis B recombinant vaccine

2010/0314/2DP/2.1.1.1.0/10/APIA/VIAA/052
Virus-like particle (VLP) nanotechnology for the generation of drug and diagnostics delivery tools

2010/0310/2DP/2.1.1.1.0/10/APIA/VIAA/069
Development of novel G protein coupled receptor assay systems for bioactive compound monitoring

 2010/0230/2DP/2.1.1.1.0/10/APIA/VIAA/075
Novel model of HBV infection and a technology for antiviral agent evaluation

 2010/0233/2DP/2.1.1.1.0/10/APIA/VIAA/076
Prognostic testing for assessment of the effectiveness of immunotherapeutic drugs: method for personalized drug usage in oncology

 2010/0261/2DP/2.1.1.1.0/10/APIA/VIAA/155
Development of effective techniques and new plant pathogen diagnostic components for obtaining virus-free planting material of fruit crops

 2010/0224/2DP/2.1.1.1.0/10/APIA/VIAA/164
Development of new type anti-HCV therapeutic individualized vaccine prototype

2013/0042/2DP/2.1.1.1.0/13/APIA/VIAA/002

Research and development of novel diagnostic methods for genetic and immunologic testing

2013/0053/2DP/2.1.1.1.0/13/APIA/VIAA/006

Technology to obtain high quality virus-like nanostructures based on HBV core-antigen

2013/0052/2DP/2.1.1.1.0/13/APIA/VIAA/019

Development of cancer-specific autoantibody assay for early detection of gastric cancer

2014/0021/2DP/2.1.1.1.0/14/APIA/VIAA/058

Development of novel in vitro tests for diagnostics and prognostics of individualized therapies of tumors and mitochondrial disease treatment

2014/0014/2DP/2.1.1.1.0/14/APIA/VIAA/013

Application of VLP technology for development of vaccine prototypes against zoonotic diseases

2014/0012/2DP/2.1.1.1.0/14/APIA/VIAA/038

Synthesis and Validation of a Novel Cyclic Growth Hormone

2015/0001/2DP/2.1.1.2.0/14/APIA/VIAA/009

Elaboration of international joint research project proposals in the area of biomedicine

2015/0023/2DP/2.1.1.3.3/15/IPIA/VIAA/005

Promoting scientific excellence and institutional development of Latvian Biomedical Research and Study Centre


 

 

BBMRI- Large Prospective Cohorts (LPC)

Vector-borne Risks for Europe: Risk assessment and control of West Nile and Chikungunya virus (VECTORIE)

Development of a universal influenza vaccine based on tandem core technology (FLUTCORE)

Quick links



Mājas lapas izstrādi finansēja ERAF 2.1.1.2. aktivitātes projekts Nr. 2010/0196/2DP/2.1.1.2.0/10/APIA/VIAA/004 "Latvijas biomedicīnas pētījumu integrācija Eiropas zinātnes telpā".